However, these observations do not constitute evidence that tirzepatide treats Hashimoto's disease itself
However, the accelerated approval pathway means that evidence is still interim: while part one of the ESSENCE trial demonstrated improvement in liver scarring and inflammation, it does not yet show whether semaglutide reduces the risk of serious outcomes such as cirrhosis, liver failure or liver cancer
Florida Surgery And Weight Loss Center is not affiliated with or endorsed by the manufacturers of these medications or by any insurance provider mentioned
For patients in Connecticut considering medical weight loss, GLP-1 therapy, peptide-based care, or body-composition-focused treatment, the more important question is not who is talking about retatrutide
Not evaluated by the MHRA.
JCI Insight 8:e170671 Delvadia P, Dhote V, Mandloi AS et al (2025) Dual GLP-1 and GIP agonist Tirzepatide exerted neuroprotective action in a parkinsons disease rat model